Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05727553 | Implementation of Online Adaptive Radiotherapy for Breast Cancer Patients on Ethos (BREAST-ART)(BREAST-ART) | completed | — | 50 | Amsterdam UMC, location VUmcOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT06025799 | Nurse-Delivered Adapted MBSR During Breast Cancer Radiotherapy | completed | N/A | 100 | Alexandria UniversityOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT07300202 | A Phase I, Single-arm, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers | completed | Phase 1 | 15 | Oriplantee Company LimitedOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT06465368 | A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause | completed | Phase 2 | 121 | PfizerINDUSTRY | 13 | Jul 15, 2026 | clinicaltrials |
| NCT07702409 | Tai-Chi Exercise Reduces Fatigue in Breast Cancer Patients Undergoing Chemotherapy | completed | N/A | 61 | Chairul HudaOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT05113927 | Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery.(RCT) | completed | N/A | 613 | Perimeter Medical ImagingINDUSTRY | 1 | Jul 13, 2026 | clinicaltrials |
| NCT02364557 | Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival | completed | Phase 2 / Phase 3 | 129 | NRG OncologyOTHER | 4 | Jul 10, 2026 | clinicaltrials |
| NCT03180294 | Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer | completed | Phase 2 | 230 | NRG OncologyOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT04717050 | Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity | completed | N/A | 64 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT05064098 | Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients | completed | — | 48 | University of Colorado, DenverOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT05377684 | Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment(ROSE) | completed | — | 450 | IpsenINDUSTRY | 1 | Jul 10, 2026 | clinicaltrials |
| NCT06003114 | A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs | completed | — | 472 | PfizerINDUSTRY | 1 | Jul 10, 2026 | clinicaltrials |
| NCT07096024 | A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market | completed | — | 95,637 | PfizerINDUSTRY | 1 | Jul 10, 2026 | clinicaltrials |
| NCT02009449 | A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors(IVY) | completed | Phase 1 | 353 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 9, 2026 | clinicaltrials |
| NCT02743910 | Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer | completed | — | 228 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 9, 2026 | clinicaltrials |
| NCT05631795 | Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment(ALPINIST) | completed | Phase 4 | 40 | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 9, 2026 | clinicaltrials |
| NCT06905639 | Impact of Physical Exercise on Lymphedema Related to Breast Cancer: Assessment Using Thermography | completed | N/A | 9 | Marta Arias CrespoOTHER | 1 | Jul 9, 2026 | clinicaltrials |
| NCT07693985 | Multimodal Exercise and Education Program in Metastatic Breast CancerMostrar más líneas(MBC_MME) | completed | N/A | 37 | University of ValenciaOTHER | 1 | Jul 9, 2026 | clinicaltrials |
| NCT03671330 | Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer. | completed | Phase 2 | 327 | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 8, 2026 | clinicaltrials |
| NCT04688762 | The E-consult Application for Patients With Breast Cancer: Interest in Empathy and Empowerment of Patients.(e-CONSULT) | completed | — | 207 | Centre Francois BaclesseOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT05365230 | A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer | completed | Phase 4 | 261 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT05565534 | Diabetes Care for Breast Cancer Patients | completed | N/A | 74 | Weill Medical College of Cornell UniversityOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT06115902 | A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer | completed | Phase 1 | 153 | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 8, 2026 | clinicaltrials |
| NCT06386263 | HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada(HER-TEMPO) | completed | — | 22 | AstraZenecaINDUSTRY | 1 | Jul 8, 2026 | clinicaltrials |
| NCT07691294 | Endoscopic Assisted Latissimus Dorsi Musculocutaneous Flap for Breast Reconstruction | completed | N/A | 15 | Kasr El Aini HospitalOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT02200705 | Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial | completed | N/A | 206 | IceCure Medical Ltd.INDUSTRY | 1 | Jul 7, 2026 | clinicaltrials |
| NCT03664687 | Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)(REaCT-ZOL) | completed | Phase 4 | 211 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT06161922 | Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based Therapy | completed | — | 600 | Fudan UniversityOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT06733155 | Trial to Evaluate the Impact of Various Interventions to Increase the Uptake of Surveillance Mammography in Eligible Women in Singapore | completed | N/A | 12,000 | National University Hospital, SingaporeOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT06177795 | Increasing Screening for Cancer Using EHR-Nudges(I-SCREEN) | completed | N/A | 21,123 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT06745804 | Study of 68Ga-R10602 | completed | Phase 1 | 27 | Radionetics OncologyINDUSTRY | 1 | Jul 6, 2026 | clinicaltrials |
| NCT00317720 | Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer | completed | Phase 1 / Phase 2 | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT02867475 | REduction of Physical Inactivity Facing the CAncer(RESCA) | completed | N/A | 420 | Centre Antoine LacassagneOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT03121469 | Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer(RPOS+) | completed | N/A | 28 | Centre Antoine LacassagneOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT04000880 | Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health(AMPLIFY) | completed | N/A | 603 | University of Alabama at BirminghamOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT04213365 | Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol)(COG STIM) | completed | N/A | 20 | Centre Francois BaclesseOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT04261153 | Use of Cognitive Stimulation Software for Patients Over the Age of 70 Followed for Breast Cancer: COG-TAB-AGE Feasibility Study(COG-TAB-AGE) | completed | N/A | 55 | Centre Francois BaclesseOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT05064085 | Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer | completed | Phase 1 | 13 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT07680296 | NIR Device for Assessment of Skin Flap Perfusion in Breast Surgery: A Pilot Interventional Study(ADisIRast) | completed | N/A | 20 | National Research Council, Institute of Clinical Physiology, ItalyOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT07680855 | ANTthracycline-induced Inflammation and OXidative Stress: 10-year Follow-up(ANTIOX-10) | completed | — | 17 | University of ChileOTHER | 0 | Jul 2, 2026 | clinicaltrials |
| NCT03179904 | TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer | completed | Phase 2 | 17 | Mayo ClinicOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT06949046 | Effects of a Nursing-led Communication Using Mobile Health Information in Breast Cancer Patients Undergoing Concurrent Chemotherapy(breast cancer) | completed | N/A | 80 | National Defense Medical Center, TaiwanOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT07678099 | Screening Colonoscopy in Breast Cancer Patients | completed | N/A | 216 | Haydarpasa Numune Training and Research HospitalOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT05043506 | European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies(EUCHARIS) | completed | — | 1,939 | PfizerINDUSTRY | 7 | Jun 30, 2026 | clinicaltrials |
| NCT07671547 | Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy(NADERIN-BC) | completed | Phase 2 / Phase 3 | 79 | MIPO ClinicOTHER | 0 | Jun 30, 2026 | clinicaltrials |
| NCT00165256 | Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast | completed | Phase 2 | 157 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT00861705 | Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery | completed | Phase 2 | 454 | National Cancer Institute (NCI)NIH | 1 | Jun 29, 2026 | clinicaltrials |
| NCT05376644 | Molecular Imaging of HER2 Expression in HER2-positive Breast Cancer Using 99mTc-ADAPT6 vs 99mTc-DARPinG3 | completed | N/A | 15 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 29, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jul 16, 2026source: clinicaltrials